Cyclopropylamines As Lsd1 Inhibitors

Abstract

The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.


Claims
Owners (US)
Download PDF
Document Preview
Document History
  • Publication: Nov 15, 2016
  • Application: Feb 12, 2015
    US US 201514620884 A
  • Priority: Feb 12, 2015
    US US 201514620884 A
  • Priority: Oct 8, 2014
    US US 201462061258 P
  • Priority: Feb 13, 2014
    US US 201461939458 P

Download Citation


Sign in to the Lens

Feedback